A picture with more details is painted for prostate cancer

Asian Journal of Andrology

Volumn 14, Issue 6, 2012, Pages 799-800

  Liu, Wennuan ^a   Feng, Junjie ^a   Xu, Jianfeng ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 12; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ETS2 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; SODIUM CHANNEL NAV1.9; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; AR PROTEIN, HUMAN; ETS2 PROTEIN, HUMAN; FOXA1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PTEN PROTEIN, HUMAN; REPRESSOR PROTEIN; SPOP PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS 2;

CANCER PATIENT; CASTRATION RESISTANT PROSTATE CANCER; GENE DELETION; GENE FREQUENCY; HUMAN; POINT MUTATION; PROSTATE CANCER; SHORT SURVEY; SIGNAL TRANSDUCTION; SOMATIC MUTATION; GENETICS; MALE; METABOLISM; MUTATION; ORCHIECTOMY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE;

GENES, TUMOR SUPPRESSOR; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MALE; MUTATION; NUCLEAR PROTEINS; ORCHIECTOMY; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEIN C-ETS-2; PTEN PHOSPHOHYDROLASE; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84869021170     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.73     Document Type: Short Survey

References (8)

1. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012; 44: 685-9.
2. Grasso CS, Wu Y-M, Robinson DR, Cao X, Dhanasekaran SM et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature; e-pub ahead of print 20 May 2012; doi: 10.038/ nature11125.
3. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470: 214-20.
4. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009; 15: 559-65.
5. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
6. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644-8. (Pubitemid 41528150)
7. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010; 466: 869-73.
8. Liu W, Lindberg J, Sui G, Luo J, Egevad L et al. Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene; epub ahead of print 5 December 2012; doi: 10.1038/ onc.2011.554.